Drug Pipeline

MK-8527 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
2
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT07528508
A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527…
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-22 NCT07600775 A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis… Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 3
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07071623 A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) Human Immunodeficiency Virus (HIV) Recruiting
NCT07044297 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1)… Human Immunodeficiency Virus (HIV) Recruiting
Phase 1
NCT07528508 A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527… Healthy Recruiting
NCT07600775 A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis… Human Immunodeficiency Virus (HIV) Not Yet Recruiting
Sponsors Running MK-8527 Trials
Get alerts when MK-8527 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free